Although existing research has associated AVPI1 with the development and progression of cancers like melanoma (Motwani et al., 2021) and prostate cancer (Li et al., 2024), its role in colorectal cancer and resistance to chemotherapy agents such as 5-FU and oxaliplatin has not yet been investigated. This evidence concerns the gene AVPI1 and melanoma.